Flow Pharma engineers and manufactures state-of-the-art biomedicines.
Our unique patented delivery systems and biotechnology are ideally suited for curative intervention in COVID-19, Ebola, and treatment-resistant cancers.
A prophylactic needle-free nebulizer treatment to prevent COVID-19 in both virus-exposed and healthy patient populations. A unique targeted T-Cell immunotherapy biomedicine designed to help cure and prevent COVID-19.
FlowVax Ebola & Marburg
Ebola, Marburg, Nebulizer
Marburg is an Ebola-like virus weaponized by hostile forces. By relying on T-cells rather than antibodies, we provide long lasting protection through enhanced immune targeting and surveillance of the hidden Ebola and Marburg virus nucleocapsid proteins.
A revolutionary approach to breast cancer that utilizes T-cell biomedicines to provide highly efficacious therapy.